HEMOPHILIA B WITH INHIBITOR

Clinical trials for HEMOPHILIA B WITH INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new HEMOPHILIA B WITH INHIBITOR trials appear

Sign up with your email to follow new studies for HEMOPHILIA B WITH INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Breakthrough treatment could prevent dangerous bleeds in Tough-to-Treat hemophilia

Disease control Ongoing

This study is testing whether a new injection called KN057 can safely prevent bleeding episodes in people with hemophilia A or B who have developed inhibitors, which make standard treatments less effective. About 53 male participants aged 12-70 will be randomly assigned to receiv…

Matched conditions: HEMOPHILIA B WITH INHIBITOR

Phase: PHASE3 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

HEMOPHILIA B WITH INHIBITOR

Get alerted when new HEMOPHILIA B WITH INHIBITOR trials appear

Breakthrough treatment could prevent dangerous bleeds in Tough-to-Treat hemophilia